Dipeptidyl nitrile derivatives suppress the Trypanosoma cruzi in vitro infection
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dipeptidyl nitrile derivatives suppress the Trypanosoma cruzi in vitro infection
Authors
Keywords
Chagas disease, Antichagasic compounds, Cell-based assays, Parasite forms, Cysteine protease inhibition, Viability
Journal
EXPERIMENTAL PARASITOLOGY
Volume 219, Issue -, Pages 108032
Publisher
Elsevier BV
Online
2020-11-01
DOI
10.1016/j.exppara.2020.108032
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synthesis and structure-activity relationship of nitrile-based cruzain inhibitors incorporating a trifluoroethylamine-based P2 amide replacement
- (2019) Juliana C. Gomes et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Trypanosoma cruzi genetic diversity: Something new for something known about Chagas disease manifestations, serodiagnosis and drug sensitivity
- (2018) Bianca Zingales ACTA TROPICA
- Development of Trypanosoma cruzi in vitro assays to identify compounds suitable for progression in Chagas’ disease drug discovery
- (2018) Lorna M. MacLean et al. PLoS Neglected Tropical Diseases
- Biological Activity and Physicochemical Properties of Dipeptidyl Nitrile Derivatives Against Pancreatic Ductal Adenocarcinoma Cells
- (2018) José Carlos Quilles et al. Anti-Cancer Agents in Medicinal Chemistry
- Anti-trypanosomal activity of non-peptidic nitrile-based cysteine protease inhibitors
- (2017) Antonio C. B. Burtoloso et al. PLoS Neglected Tropical Diseases
- Current drug therapy and pharmaceutical challenges for Chagas disease
- (2016) José Bermudez et al. ACTA TROPICA
- Cruzipain: An Update on its Potential as Chemotherapy Target against the Human Pathogen Trypanosoma cruzi
- (2015) M.H. Branquinha et al. CURRENT MEDICINAL CHEMISTRY
- Cruzain inhibitors: efforts made, current leads and a structural outlook of new hits
- (2015) Karina Martinez-Mayorga et al. DRUG DISCOVERY TODAY
- Synthesis and Evaluation of Oxyguanidine Analogues of the Cysteine Protease Inhibitor WRR-483 against Cruzain
- (2015) Brian D. Jones et al. ACS Medicinal Chemistry Letters
- Molecular Design, Synthesis and Trypanocidal Activity of Dipeptidyl Nitriles as Cruzain Inhibitors
- (2015) Leandro A. A. Avelar et al. PLoS Neglected Tropical Diseases
- Cysteine proteases as therapeutic targets: does selectivity matter? A systematic review of calpain and cathepsin inhibitors
- (2015) Marton Siklos et al. Acta Pharmaceutica Sinica B
- Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacatib Fracture Trial
- (2014) H. G. Bone et al. OSTEOPOROSIS INTERNATIONAL
- Nitroheterocyclic compounds are more efficacious than CYP51 inhibitors against Trypanosoma cruzi: implications for Chagas disease drug discovery and development
- (2014) Carolina B. Moraes et al. Scientific Reports
- Leishmania (L.) amazonensis peptidase activities inside the living cells and in their lysates
- (2012) Elide E. Caroselli et al. MOLECULAR AND BIOCHEMICAL PARASITOLOGY
- Cruzipain Promotes Trypanosoma cruzi Adhesion to Rhodnius prolixus Midgut
- (2012) Lívia Almeida Uehara et al. PLoS Neglected Tropical Diseases
- The peptidases of Trypanosoma cruzi: Digestive enzymes, virulence factors, and mediators of autophagy and programmed cell death
- (2011) Vanina E. Alvarez et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- The Trypanosoma cruzi Protease Cruzain Mediates Immune Evasion
- (2011) Patricia S. Doyle et al. PLoS Pathogens
- Cruzipain, the Major Cysteine Protease of Trypanosoma cruzi: A Sulfated Glycoprotein Antigen as Relevant Candidate for Vaccine Development and Drug Target. A Review
- (2009) Vilma Duschak et al. CURRENT MEDICINAL CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started